Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1405763 | 0.90 | DNM1 (0.46) | TSHRDNM1CA12CA1CA9 | |
| SCHEMBL4395764 | 0.90 | DNM1 (0.46) | TSHRDNM1CA12CA1CA9 | |
| SCHEMBL3251807 | 0.90 | DNM1 (0.46) | TSHRDNM1CA12CA1CA9 | |
| SCHEMBL4398444 | 0.90 | DNM1 (0.46) | TSHRDNM1CA12CA1CA9 | |
| SCHEMBL3027388 | 0.89 | TSHR (0.39) | TSHRALDH1A1DNM1LMNAALDH2 | |
| SCHEMBL1405684 | 0.86 | TSHR (0.40) | TSHRALDH1A1DNM1THRB | |
| SCHEMBL5958083 | 0.84 | TSHR (0.44) | TSHRDNM1LMNATHRB | |
| SCHEMBL317337 | 0.84 | TSHR (0.44) | TSHRDNM1LMNATHRB | |
| SCHEMBL1448478 | 0.82 | TSHR (0.33) | TSHRALDH1A1 | |
| SCHEMBL11791586 | 0.82 | ALDH1A1 (0.39) | TSHRALDH1A1LMNAALDH2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101312973-B | Indolizine derivatives, process for their preparation and pharmaceutical compositions containing them | SANOFI-AVENTIS (FR) | 2011-12-28 | — | — | CN | claimed |
| EP-1647555-B1 | THE C-GLYCOSYLISOFLAVONES HAVING ALKYLAMINOALKOXYL SUBSTITUENT, THE PREPARATION AND THE USE OF THE SAME | INST RADIATION MED AMMS PLA (CN) | 2011-04-20 | — | — | EP | claimed |
| US-7727965-B2 | C-glycosylisoflavones having alkylaminoalkoxyl substituent, preparation and use of the same | HAINAN YANGPU NEW & SPECIAL MEDICINE CO., LTD. (CN) | 2010-06-01 | — | — | US | claimed |
| US-20080293642-A1 | C-Glycosylisoflavones Having Alkylaminoalkoxyl Substituent, Preparation and Use of the Same | INSTITUTE OF RADIATION MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCES, PLA (CN) | 2008-11-27 | — | — | US | claimed |
| CN-101312973-A | Indolizine derivatives, process for their preparation and pharmaceutical compositions containing them | SANOFI AVENTIS (FR) | 2008-11-26 | — | — | CN | claimed |
| EP-1647555-A1 | THE C-GLYCOSYLISOFLAVONES HAVING ALKYLAMINOALKOXYL SUBSTITUENT, THE PREPARATION AND THE USE OF THE SAME | Institute of Radiation Medicine Academy of Military Medical Sciences of the Pla (CN) | 2006-04-19 | — | — | EP | claimed |
| US-6111045-A | YIELDS A VULCANIZED RUBBER SHOWING IMPROVEMENTS IN HEAT BUILD-UP, TENSILE STRENGTH, ABRASION RESISTANCE AND PROCESSABILITY | NIPPON ZEON CO. LTD. (JP) | 2000-08-29 | — | — | US | claimed |
| EP-0433805-A1 | N-Substituted 3-cyano-4-phenyl-pyrroles | BAYER AG (DE) | 1991-06-26 | — | — | EP | claimed |
| US-4914122-A | CONTROLLING PLANT DISEASES | BAYER AKTIENGESELLSCHAFT (DE) | 1990-04-03 | — | — | US | claimed |
| EP-0327977-A1 | 1-Aminomethyl-3-(2,4-difluor-3-chlorphenyl)-4-cyanopyrroles | BAYER AG (DE) | 1989-08-16 | — | — | EP | claimed |
| US-20240182810-A1 | LUBRICANT OIL COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-06-06 | — | — | US | disclosed |
| US-20240150670-A1 | LUBRICATING OIL ADDITIVE COMPOSITION AND LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-05-09 | — | — | US | disclosed |
| EP-4317373-A1 | LUBRICANT OIL COMPOSITION | Idemitsu Kosan Co.,Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| EP-4317386-A1 | LUBRICATING OIL ADDITIVE COMPOSITION AND LUBRICATING OIL COMPOSITION | Idemitsu Kosan Co., Ltd (JP) | 2024-02-07 | — | — | EP | disclosed |
| EP-4317378-A1 | LUBRICATING OIL COMPOSITION | Idemitsu Kosan Co.,Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-4720493-A | Thienylthiazole compounds | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1988-01-19 | — | — | US | disclosed |
| EP-0183191-A1 | Thienylthiazole compounds | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1986-06-04 | — | — | EP | disclosed |
| EP-0055728-A4 | HYDROPHILIC INTERPOLYMERS OF ACRYLIC ACID AND AN ACRYLATE. | GOODRICH CO B F (US) | 1982-08-11 | — | — | EP | disclosed |
| EP-0055728-A1 | HYDROPHILIC INTERPOLYMERS OF ACRYLIC ACID AND AN ACRYLATE | The B.F. GOODRICH Company (US) | 1982-07-14 | — | — | EP | disclosed |
| WO-1982000147-A1 | HYDROPHILIC INTERPOLYMERS OF ACRYLIC ACID AND AN ACRYLATE | GOODRICH CO B F (US) | 1982-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293642-A1 | C-Glycosylisoflavones Having Alkylaminoalkoxyl Substituent, Preparation and Use of the Same | UGCG, PIGO, GPI | TSHR 4040/4885ALDH1A1 263/4885DNM1 4047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.